Investigating how adiposomes affect blood vessel function in obesity and diabetes
Official title: Role of Adiposomes in Diabetes-Associated Endothelial Dysfunction and Restorative Effects of Exercise and Metabolic Surgery
Run by University of Illinois Chicago · NCT05199454 · Data updated 2026-11-12
This study is testing how tiny particles from fat tissue affect blood vessel health in people with obesity and diabetes, while also seeing if exercise can help improve this issue.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | May 16, 2022 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | August 17, 2026 |
| Trial ID | NCT05199454 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are obese individuals aged 18-50 with a BMI of 35 kg/m2 or higher and diagnosed with type II diabetes.
✕Probably not a fit
Patients with chronic heart, liver, or kidney diseases, autoimmune diseases, or cancer may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore the role of adiposomes, which are extracellular vesicles released from adipose tissue, in endothelial dysfunction associated with obesity and type II diabetes. The researchers will investigate how these adiposomes communicate unhealthy lipid profiles to endothelial cells, potentially contributing to cardiovascular disease. Participants will engage in a moderate-intensity exercise program to assess the impact of physical activity on the mechanisms of vascular dysfunction. The study focuses on understanding the molecular pathways involved in these conditions to develop corrective strategies.
Why it matters
Potential benefit: If successful, this study could lead to new therapeutic strategies for improving vascular health in obese diabetic patients.
How similar studies have gone: While the specific role of adiposomes in endothelial dysfunction is a novel approach, related studies have shown that targeting vascular dysfunction in obesity and diabetes can lead to significant improvements.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI ≥ 35 kg/m2 * Between ages 18-50 years * Not pregnant * Diabetic (Current use of diabetes medication or fasting glucose ≥126 mg/dL) * Medical clearance to participate in a moderate-intensity exercise program Exclusion Criteria: * Pregnant women * Current smokers * Currently abusing alcohol or drugs * Chronic heart, liver, or kidney diseases, autoimmune diseases, or cancer * Non-English speakers * History of allergic reactions to lidocaine
Where it's running
-
University of Illinois at Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Abeer M Mohamed, MD, PhD — University of Illinois Chicago
- Study coordinator: Abeer M Mohamed, MD, PhD
- Email: amahmo4@uic.edu
- Phone: 312-355-8099
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Inspire HER: a heart-health and stress-support program for Black women
This project will test whether the Inspire HER lifestyle program helps Black women with higher heart disease risk improve heart health and manage stress.
-
Effects of whole vs. nonfat milk on children's body composition
This study is testing whether kids aged 9 to 12 who drink whole milk instead of nonfat milk gain less weight and eat healthier foods.
-
A biobank for cardiovascular research at UAB
This study is collecting blood and DNA samples from people to see how genetics relate to heart disease, diabetes, and obesity, with the goal of finding better ways to prevent and treat these conditions.
-
Registry for cardiometabolic risk factors
This study is testing how different heart and metabolic health factors affect people to help prevent future heart problems.
-
Investigating heart disease risk related to obesity in African Americans
This study is trying to see how obesity and certain blood sugar levels affect the risk of heart disease in African Americans and Black Africans living in the U.S.
-
Semaglutide's effects on heart and muscle mass
This project will use MRI scans and strength tests over 12 months to see if semaglutide changes body and heart muscle in adults starting the medication.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.